Skip to content

Home Search Authors Pakistan News Saved

SciRah

SciRah does not host or store research papers. Results come live from free, official scholarly APIs, and every paper links back to its original source.

Data sources

OpenAlex
Semantic Scholar
Crossref
CORE
arXiv
PubMed

Privacy policy Terms of service

T. Kogawa · SciRah

Researcher profile · Semantic Scholar

T. Kogawa

Share profile

T. Kogawa — researcher profile on SciRah

h-index: 20
Works: 115
Citations: 1,463

Most-cited papers

Revisiting the definition of estrogen receptor positivity in HER2-negative primary breast cancer
T. Fujii, T. Kogawa, W. Dong, A. Sahin +9 more
2017Annals of Oncology148 citations Open access
Semantic Scholar
c-Jun N-terminal kinase promotes stem cell phenotype in triple-negative breast cancer through up-regulation of Notch1 via activation of c-Jun
Xuemei Xie, Tamer S. Kaoud, Ramakrishna Edupuganti, Ting-Hu Zhang +11 more
2016Oncogene99 citations Open access
Semantic Scholar
Effectiveness of an Adjuvant Chemotherapy Regimen for Early-Stage Breast Cancer
T. Fujii, Fanny Le Du, Lianchun Xiao, T. Kogawa +5 more
2015JAMA Oncology92 citations Open access
Semantic Scholar
Overall survival differences between patients with inflammatory and noninflammatory breast cancer presenting with distant metastasis at diagnosis
T. Fouad, T. Kogawa, Diane D. Liu, Yu Shen +12 more
2015Breast Cancer Research and Treatment90 citations Open access
Semantic Scholar
A first-in-human Phase 1 study of epirubicin-conjugated polymer micelles (K-912/NC-6300) in patients with advanced or recurrent solid tumors
H. Mukai, T. Kogawa, N. Matsubara, Y. Naito +2 more
2017Investigational new drugs72 citations
Semantic Scholar
Phase I dose‐escalation trial to repurpose propagermanium, an oral CCL2 inhibitor, in patients with breast cancer
Takaaki Masuda, Miwa Noda, T. Kogawa, D. Kitagawa +6 more
2020Cancer Science62 citations Open access
Semantic Scholar
The role of inflammation in inflammatory breast cancer.
T. Fouad, T. Kogawa, J. Reuben, N. Ueno
2014Advances in Experimental Medicine and Biology62 citations
Semantic Scholar
Comparison of molecular subtype distribution in triple-negative inflammatory and non-inflammatory breast cancers
H. Masuda, K. Baggerly, Ying Wang, T. Iwamoto +15 more
2013Breast Cancer Research56 citations Open access
Semantic Scholar
Erratum to: Overall survival differences between patients with inflammatory and noninflammatory breast cancer presenting with distant metastasis at diagnosis
T. Fouad, T. Kogawa, Diane D. Liu, Yu Shen +12 more
2015Breast Cancer Research and Treatment52 citations Open access
Semantic Scholar
EGFR signaling promotes inflammation and cancer stem-like activity in inflammatory breast cancer
Xiaoping Wang, Monica E. Reyes, Dong-Wei Zhang, Y. Funakoshi +13 more
2017OncoTarget51 citations Open access
Semantic Scholar
Clinical practice guidance for next‐generation sequencing in cancer diagnosis and treatment (Edition 1.0)
K. Sunami, Hideaki Takahashi, K. Tsuchihara, M. Takeda +33 more
2018Cancer Science46 citations Open access
Semantic Scholar
Histone deacetylase inhibitor enhances the efficacy of MEK inhibitor through NOXA-mediated MCL1 degradation in triple-negative and inflammatory breast cancer
Angie M. Torres-Adorno, Jangsoon Lee, T. Kogawa, P. Ordentlich +3 more
2017Clinical Cancer Research39 citations Open access
Semantic Scholar
Abstract GS1-05: Datopotamab deruxtecan in advanced/metastatic HER2- breast cancer: Results from the phase 1 TROPION-PanTumor01 study
I. Krop, D. Juric, T. Shimizu, A. Tolcher +15 more
2022Cancer Research36 citations
Semantic Scholar
Thrombocytosis as a prognostic factor in inflammatory breast cancer
K. Harano, T. Kogawa, Jimin Wu, Ying Yuan +4 more
2017Breast Cancer Research and Treatment29 citations
Semantic Scholar
Nomogram to predict pathologic complete response in HER2-positive breast cancer treated with neoadjuvant systemic therapy
T. Fujii, T. Kogawa, Jimin Wu, A. Sahin +9 more
2017British Journal of Cancer24 citations Open access
Semantic Scholar
Association of Body Mass Index Changes during Neoadjuvant Chemotherapy with Pathologic Complete Response and Clinical Outcomes in Patients with Locally Advanced Breast Cancer
T. Kogawa, T. Fouad, Cai-Miao Wei, H. Masuda +11 more
2015Journal of Cancer24 citations Open access
Semantic Scholar
High HER2/Centromeric Probe for Chromosome 17 Fluorescence In Situ Hybridization Ratio Predicts Pathologic Complete Response and Survival Outcome in Patients Receiving Neoadjuvant Systemic Therapy With Trastuzumab for HER2-Overexpressing Locally Advanced Breast Cancer.
T. Kogawa, T. Fouad, Diane D. Liu, Jimin Wu +8 more
2016The Oncologist22 citations Open access
Semantic Scholar
A phase II study of talimogene laherparepvec for patients with inoperable locoregional recurrence of breast cancer
M. Kai, A. Marx, Diane D. Liu, Yu Shen +10 more
2021Scientific Reports20 citations Open access
Semantic Scholar
Current Status of Advance Care Planning and End‐of‐life Communication for Patients with Advanced and Metastatic Breast Cancer
Yasuaki Sagara, M. Mori, Sena Yamamoto, K. Eguchi +14 more
2020The Oncologist19 citations Open access
Semantic Scholar
Single agent activity of U3-1402, a HER3-targeting antibody-drug conjugate, in breast cancer patients: Phase 1 dose escalation study.
T. Kogawa, K. Yonemori, N. Masuda, S. Takahashi +16 more
201819 citations
Semantic Scholar
Overall survival and post-progression survival are potent endpoint in phase III trials of second/third-line chemotherapy for advanced or recurrent epithelial ovarian cancer
M. Shimokawa, T. Kogawa, Takako Shimada, Toshiaki Saito +3 more
2018Journal of Cancer19 citations Open access
Semantic Scholar
LBA4 Datopotamab deruxtecan (Dato-DXd), a TROP2-directed antibody-drug conjugate (ADC), for triple-negative breast cancer (TNBC): Preliminary results from an ongoing phase I trial
A. Bardia, D. Juric, Toshio Shimizu, A. Tolcher +16 more
202118 citations Open access
Semantic Scholar
Multi-omics analyses identify HSD17B4 methylation-silencing as a predictive and response marker of HER2-positive breast cancer to HER2-directed therapy
S. Yamashita, Naoko Hattori, S. Fujii, Takeshi Yamaguchi +10 more
2020Scientific Reports17 citations Open access
Semantic Scholar
Impact of change in body mass index during neoadjuvant chemotherapy and survival among breast cancer subtypes
T. Kogawa, T. Fujii, T. Fouad, Diane D. Liu +9 more
2018Breast Cancer Research and Treatment17 citations
Semantic Scholar
Abstract P6-10-03: Datopotamab Deruxtecan (Dato-DXd) in Advanced Triple-Negative Breast Cancer (TNBC): Updated Results From the Phase 1 TROPION-PanTumor01 Study
A. Bardia, I. Krop, F. Meric-Bernstam, A. Tolcher +13 more
2023Cancer Research16 citations
Semantic Scholar
Abstract PD13-08: PD13-08 Phase 1 TROPION-PanTumor01 Study Evaluating Datopotamab Deruxtecan (Dato-DXd) in Unresectable or Metastatic Hormone Receptor–Positive/HER2–Negative Breast Cancer (BC)
F. Meric-Bernstam, I. Krop, D. Juric, T. Kogawa +12 more
2023Cancer Research15 citations
Semantic Scholar
Reverse phase protein array identification of triple-negative breast cancer subtypes and comparison with mRNA molecular subtypes
H. Masuda, Yuan Qi, Shu-Ying Liu, N. Hayashi +4 more
2017OncoTarget14 citations Open access
Semantic Scholar
The safety and tolerability of epacadostat alone and in combination with pembrolizumab in patients with advanced solid tumors: results from a first-in-Japanese phase I study (KEYNOTE-434)
T. Doi, Y. Fujiwara, K. Shitara, Toshio Shimizu +11 more
2020Investigational new drugs12 citations
Semantic Scholar
Abstract PD1-03: Single agent activity of U3-1402, a HER3-targeting antibody-drug conjugate, in HER3-overexpressing metastatic breast cancer: Updated results of a phase 1/2 trial
N. Masuda, K. Yonemori, S. Takahashi, T. Kogawa +15 more
2019Poster Discussion Abstracts12 citations
Semantic Scholar
Maternal Embryonic Leucine Zipper Kinase is Associated with Metastasis in Triple-negative Breast Cancer
Xuemei Xie, Gaurav B Chauhan, Ramakrishna Edupuganti, T. Kogawa +21 more
2023Cancer Research Communications11 citations Open access
Semantic Scholar
Phase 1 study of the liposomal formulation of eribulin (E7389-LF): Results from the breast cancer expansion cohort.
N. Masuda, M. Ono, T. Mukohara, H. Yasojima +15 more
2022European Journal of Cancer10 citations Open access
Semantic Scholar
The impact of obesity and endocrine therapy on the prognosis of premenopausal women with hormone receptor‐positive breast cancer: A single‐institute retrospective study
Y. Ozaki, J. Masuda, A. Kataoka, T. Kogawa +7 more
2022Cancer Reports10 citations Open access
Semantic Scholar
Safety, pharmacokinetics, and preliminary efficacy of the PARP inhibitor talazoparib in Japanese patients with advanced solid tumors: phase 1 study
Y. Naito, Y. Kuboki, M. Ikeda, K. Harano +6 more
2021Investigational new drugs9 citations Open access
Semantic Scholar
Pooled analysis of combination antiemetic therapy for chemotherapy-induced nausea and vomiting in patients with colorectal cancer treated with oxaliplatin-based chemotherapy of moderate emetic risk
M. Shimokawa, Toshinobu Hayashi, J. Nishimura, T. Satoh +5 more
2021BMC Cancer9 citations Open access
Semantic Scholar
Evaluation of Combination Antiemetic Therapy on CINV in Patients With Gynecologic Cancer Receiving TC Chemotherapy
M. Shimokawa, Toshinobu Hayashi, T. Kogawa, R. Matsui +5 more
2018Anticancer Research9 citations Open access
Semantic Scholar
Chemoprevention of pancreatic cancer by inhibition of glutathione-S transferase P1
T. Kogawa, Yasushi Sato, R. Shimoyama, Wataru Kurata +2 more
2021Investigational new drugs8 citations Open access
Semantic Scholar
Chilblain lupus-like cutaneous reaction associated with systemic lupus erythematosus induced by immune checkpoint inhibitor.
Koichi Takeda, K. Nakano, Shohei Udagawa, N. Fukuda +9 more
2021Rheumatology8 citations
Semantic Scholar
The efficacy and safety of paclitaxel plus bevacizumab therapy in breast cancer patients with visceral crisis
C. Funasaka, Y. Naito, S. Kusuhara, T. Nakao +11 more
2021Breast7 citations Open access
Semantic Scholar
Clinical characteristics and outcome of bone-only metastasis in inflammatory and noninflammatory breast cancers.
M. Kai, T. Kogawa, Diane D. Liu, T. Fouad +7 more
2015Clinical Breast Cancer7 citations
Semantic Scholar
Prognostic Value of HER2 to CEP17 Ratio on Fluorescence In Situ Hybridization Ratio in Patients with Nonmetastatic HER2-Positive Inflammatory and Noninflammatory Breast Cancer Treated with Neoadjuvant Chemotherapy with or without Trastuzumab.
T. Kogawa, T. Fujii, Jimin Wu, K. Harano +11 more
2020The Oncologist6 citations Open access
Semantic Scholar
Phase 1/2, multicenter, non-randomized, open-label, multiple-dose first-in-human study of U3-1402 (anti-HER3 antibody drug conjugate) in subjects with HER3-positive metastatic breast cancer.
T. Kogawa, K. Yonemori, Y. Naito, E. Noguchi +10 more
20176 citations
Semantic Scholar
Palbociclib (P) plus tamoxifen (TAM) ± goserelin in women with hormone receptor-positive (HR+)/HER2-negative (HER2−) advanced breast cancer (ABC): Primary results of NCCH1607/PATHWAY, an Asian international double-blind randomized phase 3 trial.
T. Kogawa, E. Noguchi, T. Yamanaka, N. Yamamoto +16 more
2023Journal of Clinical Oncology5 citations
Semantic Scholar
Use of eribulin as an earlier-line chemotherapy for patients with HER2-negative metastatic breast cancer
S. Shingaki, T. Kogawa, M. Shimokawa, K. Harano +9 more
2020Journal of Cancer5 citations Open access
Semantic Scholar
264P Increased membrane HER3 expression in brain metastases compared to primary tumors in breast cancer
S. Kusuhara, T. Kogawa, M. Shimokawa, C. Funasaka +15 more
2022Annals of Oncology4 citations Open access
Semantic Scholar
Neo-Bioscore in Guiding Post-surgical Therapy in Patients With Triple-negative Breast Cancer Who Received Neoadjuvant Chemotherapy
Y. Hasegawa, N. Matsubara, T. Kogawa, Y. Naito +6 more
2021In Vivo4 citations Open access
Semantic Scholar
The utility of immunohistochemistry-based biomarkers in predicting the pathological complete response in early-stage triple-negative breast cancer.
C. Funasaka, T. Kogawa, N. Sakamoto, S. Kusuhara +14 more
2025Cancer Treatment and Research Communications3 citations Open access
Semantic Scholar
Myocarditis associated with immune-checkpoint inhibitors diagnosed by cardiac magnetic resonance imaging
M. Fukumitsu, R. Ariyasu, Mitsutomi Ishiyama, T. Mochizuki +9 more
2022International Cancer Conference Journal3 citations
Semantic Scholar
Cisplatin and S‐1 for urachal carcinoma: A single‐institution case series
T. Urasaki, Y. Naito, N. Matsubara, Masaoki Sasaki +2 more
2019IJU Case Reports3 citations Open access
Semantic Scholar
Abstract A204: INCB024360 (Epacadostat) monotherapy and in combination with pembrolizumab in patients with advanced solid tumors: primary results from first-in-Japanese phase I study (KEYNOTE-434)
Y. Fujiwara, K. Shitara, Toshio Shimizu, K. Yonemori +11 more
20183 citations
Semantic Scholar
Mitigation of paclitaxel-induced peripheral neuropathy in breast cancer patients using limb-cooling apparatus: a study protocol for a randomized controlled trial
C. Funasaka, A. Hanai, S. Zenda, K. Mori +16 more
2023Frontiers in Oncology2 citations Open access
Semantic Scholar

Frequent co-authors

Invite them to SciRah by sharing their profile.

N. Ueno×19
Invite
N. Ueno — researcher profile on SciRah
Y. Naito×12
Invite
Y. Naito — researcher profile on SciRah
K. Harano×11
Invite
K. Harano — researcher profile on SciRah
N. Matsubara×10
Invite
N. Matsubara — researcher profile on SciRah

×10

Invite

T. Mukohara — researcher profile on SciRah

Invite

D. Tripathy — researcher profile on SciRah

Invite

H. Masuda — researcher profile on SciRah

Invite

Yu Shen — researcher profile on SciRah

Invite

T. Fouad — researcher profile on SciRah

Diane D. Liu×8

Invite

Diane D. Liu — researcher profile on SciRah

Invite

K. Yonemori — researcher profile on SciRah

Invite

T. Fujii — researcher profile on SciRah